News

Glucotim LA of Centaur Pharma is an original research formulation of Timolol Long Acting developed by Senju. Centaur Pharma has introduced the vial for the first time in

As per the terms of the modification Elan will pay $9m to Transition at the time of signing the modified agreement and will also pay $11m upon the

Motavizumab is an investigational monoclonal antibody that was being considered to help prevent RSV disease. AstraZeneca has requested withdrawal of the biological license application (BLA) pending at the

The acquisition adds the APEX information management system – enabled with an advanced speech recognition and speech understanding engine – to Accentus’ technology base, driving significant cost savings

The study enrolled patients with previously untreated CUP, were randomized into one of two treatment arms: Belinostat + carboplatin and paclitaxel (BelCaP), or carboplatin and paclitaxel (CaP). The

He previously served as a member of the Cephalon executive management team in the roles of chief operating officer and chief financial officer. Additionally, for the last seven

Dynavax said that the candidate vaccine, DV-601, is designed to induce an immune response against HBV-infected cells and if proven to be safe and effective, may offer an

In its CRL the FDA said that it will not approve the application as it is. The FDA further said that the 0.5ml formulation contained the same active

The NDA seeks approval to market Iluvien (fluocinolone acetonide intravitreal insert), an investigational, sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for the treatment of